AstraZeneca released results from the TROPION-Breast01 Phase 3 trial of datopotamab deruxtecan, showing no statistically ...
According to MedImmune, the AstraZeneca subsidiary that makes FluMist, studies have shown that people ages 18 to 49 can successfully give the vaccine, and it's just as effective as having a doctor ...
AstraZeneca has announced that FluMist has been approved in the US as the self-administered influenza vaccine. FluMist, a ...
AstraZeneca's FluMist influenza vaccine, which can be self-administered. Experts hope an option for at-home flu vaccination ...